Literature DB >> 27239560

Platelet-Activating Factor-Receptor and Tumor Immunity.

Ravi P Sahu1, Raymond L Konger1, Jeffrey B Travers2.   

Abstract

First described in 1972 by Benveniste and colleagues, platelet-activating factor (PAF) remains one of the potent phospholipid known to date. The role of PAF produced enzymatically in mediating diverse biological and pathophysiological processes including inflammatory and allergic diseases and cancers in response to various stimuli has been extensively studied. However, little is known about the role of non-enzymatically-generated PAF-like lipids produced in response to pro-oxidative stressors, particularly in modulating the host immune responses to tumor immunity, which is the focus of this review.

Entities:  

Year:  2014        PMID： 27239560      PMCID： PMC4880409     

Source DB:  PubMed          Journal:  JSM Cell Dev Biol        ISSN： 2379-061X


  16 in total

1.  Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.

Authors:  Vladislava O Melnikova; Alexandra A Mourad-Zeidan; Dina Chelouche Lev; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

Review 2.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

Review 3.  Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.

Authors:  Nikki B Marshall; Nancy I Kerkvliet
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.

Authors:  Ravi P Sahu; Amal A Kozman; Yongxue Yao; Sonia C DaSilva; Samin Rezania; Kellie C Martel; Simon J Warren; Jeffrey B Travers; Raymond L Konger
Journal:  Carcinogenesis       Date:  2012-01-04       Impact factor: 4.944

5.  The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines.

Authors:  Tao Li; Michael D Southall; Qiaofang Yi; Yong Pei; Davina Lewis; Mohammed Al-Hassani; Dan Spandau; Jeffrey B Travers
Journal:  J Biol Chem       Date:  2003-02-24       Impact factor: 5.157

6.  Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.

Authors:  Yongxue Yao; Jay E Wolverton; Qiwei Zhang; Gopal K Marathe; Mohammed Al-Hassani; Raymond L Konger; Jeffrey B Travers
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression.

Authors:  Gerardo Ramos; Nasser Kazimi; Dat X Nghiem; Jeffrey P Walterscheid; Stephen E Ullrich
Journal:  Toxicol Appl Pharmacol       Date:  2004-03-15       Impact factor: 4.219

Review 8.  Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.

Authors:  Raymond L Konger; Gopal K Marathe; Yongxue Yao; Qiwei Zhang; Jeffrey B Travers
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-05-02       Impact factor: 3.072

9.  Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.

Authors:  Ana Claudia Onuchic; Camila M L Machado; Renata F Saito; Francisco J Rios; Sônia Jancar; Roger Chammas
Journal:  Mediators Inflamm       Date:  2012-04-18       Impact factor: 4.711

10.  Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.

Authors:  Patrick C Hackler; Sarah Reuss; Raymond L Konger; Jeffrey B Travers; Ravi P Sahu
Journal:  Cancer Growth Metastasis       Date:  2014-06-19
View more
  5 in total

Review 1.  MicroRNA heterogeneity in melanoma progression.

Authors:  Anita Thyagarajan; Kenneth Y Tsai; Ravi P Sahu
Journal:  Semin Cancer Biol       Date:  2019-06-01       Impact factor: 15.707

Review 2.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

3.  Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.

Authors:  Tomomi Shida-Sakazume; Yosuke Endo-Sakamoto; Motoharu Unozawa; Chonji Fukumoto; Ken Shimada; Atsushi Kasamatsu; Katsunori Ogawara; Hidetaka Yokoe; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

4.  Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.

Authors:  Anita Thyagarajan; Jeremiah Saylae; Ravi P Sahu
Journal:  Oncotarget       Date:  2017-07-25

5.  Implications of Aspirin for Melanoma Treatment: A Short Perspective.

Authors:  Anita Thyagarajan; Ravi P Sahu
Journal:  J Mol Genet Med (Lond)       Date:  2017-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.